Enveric Biosciences Inc vs Centrus Energy Corp — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Centrus Energy Corp trades at $146.62 (market cap $3.08B). The key difference: Centrus Energy Corp is far larger — about 578.9× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | LEU | |
|---|---|---|
Market Cap | $5.32M | $3.08B |
Sector | Health | Energy |
52-Week High | $17.40 | $436.00 |
52-Week Low | $1.28 | $146.61 |
Enterprise Value | $408.82K | $2.39B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Centrus Energy (LEU) trades at $147.83, down 7.25% today, with a bearish technical signal from moving averages. The stock shows mixed fundamentals with a high P/E of 56.92 but strong recent contract wins, including a $1 billion DOE award for nuclear fuel production. Recent earnings beat expectations in Q1 2026 but missed in prior quarters. Positive news includes inclusion in the S&P SmallCap 600 and a letter of intent with Oklo for HALEU supply.
Outlook is cautiously optimistic due to strategic government contracts and nuclear industry tailwinds, but high valuation and recent earnings misses pose risks. Analyst consensus is a Buy with a $223.14 price target, implying significant upside. Key risks include execution on new contracts and volatility in uranium markets.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →